Black Friday Weekend Sale : Save 30% or more on all our guides and exclusive bundle offers. Learn more

Studies related to Cognitive Decline and DMAE

Effect Of Six Months Of Treatment With V0191 In Patients With Suspected Prodromal Alzheimer's Disease

Effect None
Trial Design Double blind
Trial Length n/a
Number of Subjects 241
Sex Both Genders
Age Range 65+
Notes for this study:
No significant effect of 1500mg DMAE pyroglutamate over 24 weeks in persons with cognitive decline